Chronic treatment with losartan ameliorates vascular dysfunction induced by aging in spontaneously hypertensive rats. 1998

R Maeso, and E Rodrigo, and R Muñoz-García, and J Navarro-Cid, and L M Ruilope, and V Cachofeiro, and V Lahera
Department of Physiology, School of Medicine, Complutense University, Madrid, Spain.

OBJECTIVE To evaluate the effects of prolonged treatment with losartan on endothelium-dependent and endothelium-independent relaxations of aortic rings from adult and senescent spontaneously hypertensive rats, and to clarify whether these effects were due to specific mechanisms of the drug or a consequence of its blood-pressure-lowering action. METHODS Adult (aged 5 months) and senescent (aged 20 months) male spontaneously hypertensive rats were treated for 12 consecutive weeks with 10 mg/kg per day losartan. Systolic blood pressure and plasma concentration of nitrates were evaluated. We studied endothelium-dependent and endothelium-independent relaxations and response to angiotensin II of aortic rings from rats of each group. The direct effects of angiotensin II type 1 receptor antagonism on vascular reactivity of aortic rings from untreated adult and senescent rats that had been incubated beforehand with losartan were also studied. RESULTS Losartan treatment comparably reduced blood pressure and increased plasma concentration of nitrates in rats of both age groups. Responses to acetylcholine and sodium nitroprusside were lower for rings from senescent than they were for rings from adult rats. Constrictor responses to angiotensin II were higher for rings from senescent than they were for rings from adult rats. Treatment with losartan increased the magnitude of relaxations in response to acetylcholine for rings from rats in both groups, but increased the magnitude of relaxations in response to nitroprusside only for rings from senescent spontaneously hypertensive rats. Incubation beforehand of aortic rings from untreated rats with losartan enhanced magnitude of relaxations in response both to acetylcholine and to nitroprusside only for rings from senescent spontaneously hypertensive rats. CONCLUSIONS The consequences of aging for endothelium-dependent and endothelium-independent relaxations of rings from spontaneously hypertensive rats are ameliorated by losartan treatment, suggesting that angiotensin II plays a role via type 1 receptors. The effects of losartan on senescent spontaneously hypertensive rats were due not only to its blood-pressure-lowering action but also to the blockade of specific mechanisms derived from angiotensin II type 1 receptor antagonism, which might involve an increase in availability of NO.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D001011 Aorta The main trunk of the systemic arteries. Aortas
D014664 Vasodilation The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE. Vasodilatation,Vasorelaxation,Vascular Endothelium-Dependent Relaxation,Endothelium-Dependent Relaxation, Vascular,Relaxation, Vascular Endothelium-Dependent,Vascular Endothelium Dependent Relaxation
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

R Maeso, and E Rodrigo, and R Muñoz-García, and J Navarro-Cid, and L M Ruilope, and V Cachofeiro, and V Lahera
May 2019, American journal of hypertension,
R Maeso, and E Rodrigo, and R Muñoz-García, and J Navarro-Cid, and L M Ruilope, and V Cachofeiro, and V Lahera
May 2012, Urology,
R Maeso, and E Rodrigo, and R Muñoz-García, and J Navarro-Cid, and L M Ruilope, and V Cachofeiro, and V Lahera
August 1998, Journal of cardiovascular pharmacology,
R Maeso, and E Rodrigo, and R Muñoz-García, and J Navarro-Cid, and L M Ruilope, and V Cachofeiro, and V Lahera
June 1995, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
R Maeso, and E Rodrigo, and R Muñoz-García, and J Navarro-Cid, and L M Ruilope, and V Cachofeiro, and V Lahera
June 2006, American journal of physiology. Regulatory, integrative and comparative physiology,
R Maeso, and E Rodrigo, and R Muñoz-García, and J Navarro-Cid, and L M Ruilope, and V Cachofeiro, and V Lahera
August 1993, The Journal of pharmacology and experimental therapeutics,
R Maeso, and E Rodrigo, and R Muñoz-García, and J Navarro-Cid, and L M Ruilope, and V Cachofeiro, and V Lahera
September 1996, Hypertension (Dallas, Tex. : 1979),
R Maeso, and E Rodrigo, and R Muñoz-García, and J Navarro-Cid, and L M Ruilope, and V Cachofeiro, and V Lahera
April 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
R Maeso, and E Rodrigo, and R Muñoz-García, and J Navarro-Cid, and L M Ruilope, and V Cachofeiro, and V Lahera
April 2011, Clinical and experimental pharmacology & physiology,
R Maeso, and E Rodrigo, and R Muñoz-García, and J Navarro-Cid, and L M Ruilope, and V Cachofeiro, and V Lahera
June 1999, Journal of hypertension,
Copied contents to your clipboard!